Tool overview
Enjamb is listed under AI for Science AI tools.
What is Enjamb?
Enjamb is an agentic workspace for pharmaceutical and life-science teams. It unifies evidence synthesis, experimental planning, statistical programming, regulatory writing, files, compute, and collaboration across a drug program.
Best for
Life-science teams coordinating evidence, analysis, and regulatory deliverables
Who is it for?
Decision note
Suitable for evaluation after confirming final commercial terms, permissions, data handling, current product scope, and edit-screen aliases. Keep Needs Review enabled until a human verifies the published profile.
Key features
Literature review across large scientific corpora
Clinical evidence synthesis and protocol planning
Sandboxed Python and R statistical analysis
Regulatory writing and submission support
Shared files, projects, storage, and team roles
Use cases
Review evidence for a drug program
Design and document research methods
Run biostatistical analysis and figures
Prepare regulatory and scientific materials
Pros
- Covers multiple stages of drug development
- Combines scientific files with executable analysis
- Publishes transparent self-service pricing
Limitations
Enjamb can accelerate scientific and regulatory work but does not replace qualified researchers, biostatisticians, clinicians, quality teams, or regulatory professionals. Validate methods, citations, code, figures, and submission-critical content before use.
Pricing details
Billing options
Pricing note
The official pricing page lists a continuing Free plan, Pro at $20 per month billed annually, Max at $40 per month billed annually, Lab at $40 per seat per month billed annually, and custom Enterprise terms. No separate public free trial is listed.
Supported languages
- English
Integrations
Benchling
Veeva
Medidata
SAS
Zotero
GitHub
Please log in to join the discussion.